(Q34191947)

31 July 2017

Retrovirally introduced prostaglandin D2 synthase suppresses lung injury induced by bleomycin (English)

1 reference

31 July 2017

1 reference

Miyuki Ando

1

1 reference

31 July 2017

Yousuke Murakami

2

1 reference

31 July 2017

Fumiaki Kojima

3

1 reference

31 July 2017

Hirahito Endo

4

1 reference

31 July 2017

Hidero Kitasato

5

1 reference

31 July 2017

Atsushi Hashimoto

6

1 reference

31 July 2017

Hirosuke Kobayashi

7

1 reference

31 July 2017

Masataka Majima

8

1 reference

31 July 2017

Matsuhisa Inoue

9

1 reference

31 July 2017

Hirobumi Kondo

10

1 reference

31 July 2017

Shinichi Kawai

11

1 reference

31 July 2017

Izumi Hayashi

12

1 reference

31 July 2017

1 May 2003

1 reference

American Journal of Respiratory Cell and Molecular Biology

31 July 2017

1 reference

31 July 2017

28

1 reference

31 July 2017

5

1 reference

31 July 2017

582-591

1 reference

Idiopathic Pulmonary Fibrosis

31 July 2017

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Bleomycin-induced pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Altered immunohistochemical localization of basic fibroblast growth factor after bleomycin-induced lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Pulmonary fibrosis: a cellular overreaction or a failure of communication?

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Cyclooxygenase-2 overexpression, using an integrin-targeted gene delivery system (the LID vector), inhibits fibroblast proliferation in vitro and leads to increased prostaglandin E(2) in the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Prostaglandins as modulators of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor gamma in rheumatoid synovial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Roles of PPARs in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Role of cyclopentenone prostaglandins in rat carrageenin pleurisy

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Mechanisms of pulmonary fibrosis: conference summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

The value of edema fluid protein measurement in patients with pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0162OC

21 January 2018

Identifiers

DOI

10.1165/RCMB.2002-0162OC

1 reference

31 July 2017

1 reference